Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding trial of estriol vaginal ring VR 102 in postmenopausal women with vaginal atrophy
2024-514302-31-00Phase 2Completed
- Sponsor
- SocraTec R&D
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estriol and VR102 in vaginal atrophy (4 arms), sponsored by SocraTec R&D. Primary endpoints: Change from baseline in vaginal Maturation Value, Change from baseline in vaginal superficial cells and 4 more. Started Jul 2025; status: completed.
02
Drugs
estriolVR102
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2024-514302-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514302-31-00.